Discover
AAPG
Ascentage Pharma Group International
18.37
3 x 8.08
1 x 29.30
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | -29.99% | |
| 1y | -53.74% |
18.58
day range
19.40
16.36
52 week range
48.45
| Open | 18.58 | Prev Close | 18.37 | Low | 18.58 | High | 19.40 | Mkt Cap | 1.71B |
| Vol | 32.00 | Avg Vol | 11.47K | EPS | -1.61 | P/E | -11.38 | Forward P/E | -16.78 |
| Beta | 0.09 | Short Ratio | 8.42 | Inst. Own | 0.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-25 | 50-d Avg | 18.89 | 200-d Avg | 25.88 | 1yr Est | 47.56 |
| Income Statement | |||
| Weighted Average Shares | 349.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.47B | ||
| Cash and Equivalents (USD) | 350.86M | ||
| Investments | 37.03M | ||
| Investments Non-Current | 37.03M | ||
| Trade and Non-Trade Receivables | 252.94M | ||
| Current Assets | 2.94B | ||
| Property, Plant & Equipment Net | 829.06M | ||
| Total Assets | 3.95B | ||
| Debt Current | 1.22B | ||
| Total Debt | 1.98B | ||
| Current Liabilities | 1.64B | ||
| Debt Non-Current | 757.24M | ||
| Total Liabilities | 2.63B | ||
| Accumulated Retained Earnings (Deficit) | -7.01B | ||
| Accumulated Other Comprehensive Income | -179.09M | ||
| Shareholders Equity | 1.32B | ||
| Shareholders Equity (USD) | 188.13M | ||
| Assets Non-Current | 1.02B | ||
| Total Debt (USD) | 281.21M | ||
| Deferred Revenue | 254.21M | ||
| Goodwill and Intangible Assets | 90.63M | ||
| Inventory | 28.62M | ||
| Liabilities Non-Current | 985.99M | ||
| Trade and Non-Trade Payables | 383.41M | ||
| Tax Assets | 31.96M | ||